Research theme for competitive and other funds (2)：
2024 - 2027 DLBCLのゲノム解析によるCAR-T療法の効果予測
2021 - 2024 悪性リンパ腫におけるT細胞受容体レパトアと免疫微小環境の解析
Papers (33)：
Taichi Tamura, Yusuke Kanemasa, Shohei Nakamura, Toshihiro Okuya, Yu Yagi, Shinichiro Matsuda, Mitsutaka Murata, Kazuya Endo, Kentaro Hara, Hiroko Okinaga, et al. Management of HER2-positive and microsatellite instability-high advanced gastric cancer: a case report. International cancer conference journal. 2024. 13. 4. 342-347
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Sotaro Goto, Yasuhiko Yamamura, Yusuke Masuda, Kumiko Fujita, Kento Ishimine, Yudai Hayashi, Mano Mino, et al. Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy. Journal of clinical and experimental hematopathology : JCEH. 2024. 64. 2. 107-118
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Mina Sei, Takuma Matsuo, Kento Ishimine, Yudai Hayashi, Mano Mino, An Ohigashi, Yuka Morita, et al. Clinical outcomes in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma after second-line salvage chemotherapy: A retrospective study. Cancer medicine. 2023. 12. 17. 17808-17821
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Shunichi Okumura, Takako Watanabe, Kento Ishimine, Yudai Hayashi, Mano Mino, An Ohigashi, Yuka Morita, et al. Hemoglobin-platelet index as a prognostic factor in patients with peripheral T-cell lymphoma. EJHaem. 2023. 4. 3. 656-666
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Sotaro Goto, Yasuhiko Yamamura, Kento Ishimine, Yudai Hayashi, Mano Mino, An Ohigashi, Yuka Morita, et al. Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma. Annals of hematology. 2023. 102. 6. 1485-1500
